Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy

BACKGROUND: Recently, immunotherapies have been approved for advanced muscle invasive bladder cancer (MIBC) treatment, but only a small fraction of MIBC patients could achieve a durable drug response. Our study is aimed at identifying tumor microenvironment (TME) subtypes that have different immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhifeng, Li, Xiqing, Wang, Xiaoqing, Liu, Jie, Wang, Lingdian, Wei, Wei, Duan, Xiaoyu, Ding, Degang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170513/
https://www.ncbi.nlm.nih.gov/pubmed/35677536
http://dx.doi.org/10.1155/2022/6737241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170513/
https://www.ncbi.nlm.nih.gov/pubmed/35677536
http://dx.doi.org/10.1155/2022/6737241

Ejemplares similares